Medical Microbiology
EUCAST susceptibility testing
Medical Microbiology
EUCAST susceptibility testing
9am – 9.30am BST, 23 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Update on EUCAST guidance, provided by Kirsten Winterburn on behalf of the British Society of Antimicrobial Chemotherapy antimicrobial susceptibility testing working party.
Learning outcomes
Delegates will learn what is in development, where are the gaps and real world guidance on how to maximise the method for your laboratory.
Speakers

Kirsten Winterburn
Senior Biomedical Scientist & Quality Lead, Public Health Wales, Swansea
Integrating microbiology with clinical teams in low- and middle-income countries through the Commonwealth Partnerships for Antimicrobial Stewardship
Medical Microbiology
Integrating microbiology with clinical teams in low- and middle-income countries through the Commonwealth Partnerships for Antimicrobial Stewardship
9.30am – 10am BST, 23 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
Delegates will:
- Be familiar with the microbiology challenges faced in resource limited settings
- Understand ways in which microbiology services can be adapted in resource limited settings
- Understand how microbiology and clinical teams can interact to support antimicrobial stewardship programmes
- Learn from a case-study of a health partnership operating a Hub and Spoke model in Uganda to improve antimicrobial stewardship
Speakers
Dr Jody Winter BSc (Hons), PhD, SFHEA
Principal Lecturer in Microbiology, Nottingham Trent University
Introducing the British Society for Antimicrobial Chemotherapy (BSAC) Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS): Saving the world one visit at a time
Medical Microbiology
Introducing the British Society for Antimicrobial Chemotherapy (BSAC) Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS): Saving the world one visit at a time
10.30am – 11am BST, 23 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Antibiotics and other antimicrobials underpin all of medicine. However, the emergence and spread of resistance to these drugs is reaching a crisis point. Recent advances in clinical practice are threatened by an increasing inability to treat or prevent life-threatening infections.
Learning outcomes
This presentation will:
- Set out the extent of global antimicrobial resistance and the need for action to preserve these priceless drugs
- Describe the roles of antimicrobial stewardship, microbiology laboratory practice, and infection prevention in tackling resistance
- Explain the principles and practice of accreditation
- Introduce the BSAC Global Antimicrobial Stewardship Accreditation Scheme, including the roles of biomedical scientists in helping save the world!
Speakers
Dr David Jenkins
Vice President, British Society for Antimicrobial Chemotherapy (BSAC)
Investigating antimicrobial resistance at the national reference laboratory
Medical Microbiology
Investigating antimicrobial resistance at the national reference laboratory
11am – 11.30am BST, 23 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
This presentation will describe the role (with examples) that UKHSA’s Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit plays in: i) antimicrobial susceptibility testing and detection of AMR determinants (including new resistance mechanisms); ii) use of genomics to support outbreak investigations and assess transmission of resistance mechanisms; and iii) supporting the NHS Antimicrobial Product Subscription Model.
Speakers
Patient experience of AMR
Medical Microbiology
Patient experience of AMR
11.30am – 12pm BST, 23 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Learning outcomes
Speakers

Dr Riina Richardson
Honorary Consultant Mycologist and Clinical Senior Lecturer in Infectious Diseases and Medical Education and Clinical Head of Service , NHS Mycology Reference Centre Manchester, Manchester University NHS Foundation Trust
Changes in fungal taxonomy: Mycological rationale and clinical implications Prof. Andy
Medical Microbiology
Changes in fungal taxonomy: Mycological rationale and clinical implications Prof. Andy
9am – 9.30am BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Here, we summarize those changes affecting key groups of fungi of medical importance, explaining the mycological (taxonomic) rationale that underpinned the changes and the clinical relevance/importance (where such exists) of the key nomenclatural revisions. Potential mechanisms to mitigate unnecessary taxonomic instability are suggested, together with approaches to raise awareness of important changes to minimize potential clinical confusion.
Speakers
Update on anaerobes with focus on Fusobacterium necrophorum
Medical Microbiology
Update on anaerobes with focus on Fusobacterium necrophorum
9.30am – 10am BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
This presentation will:
- Provide delegates with an update on antimicrobial resistance in anaerobic bacteria
- Focus on Fusobacterium necrophorum and Lemierres disease and patient perspective
- Review of key taxonomic changes and recent clinical associations
Speakers

Dr Michael Perry
Deputy Lead Scientist, UK Anaerobe Reference Unit, Public Health Wales
An infection prevention and control scientist’s perspective on outbreak management
Medical Microbiology
An infection prevention and control scientist’s perspective on outbreak management
10.30am – 11am BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
Delegates gain knowledge on:
- Utility of prospective genomics for outbreak detection and management
- The impact of a multidisciplinary approach to infection prevention and control
- The role of scientists in infection prevention and control, illustrated by case studies.
Speakers
The use of simulation and physical mock-ups to study the colonisation and spread of pathogens within the indoor environment
Medical Microbiology
The use of simulation and physical mock-ups to study the colonisation and spread of pathogens within the indoor environment
11am – 11.30am BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Dr Moore will present her innovative methods of understanding the transmission of infections in model systems.
Dr Moore's studies are laboratory-based or carried out in the clinical setting and incorporate a wide variety of microbiological and aerobiological techniques. Research also involves the design, development and use of large-scale model systems, including a full-scale, fully functional hospital ward.
Speakers
The role of microbiology in the management of cystic fibrosis
Medical Microbiology
The role of microbiology in the management of cystic fibrosis
11.30am – 12pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
- Summary of pertinent recent research affecting CF patients and the delivery of diagnostic microbiology services
- The changes to the CF lungs following increased use of modulatory therapies
- The use of Microbiome studies in CF
Speakers
Multidrug-resistant Gram-negative rods (MDRGNRs) in hospital waste water
Medical Microbiology
Multidrug-resistant Gram-negative rods (MDRGNRs) in hospital waste water
2pm – 2.30pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
Is antimicrobial resistance in freshwater environments a public health risk?
Medical Microbiology
Is antimicrobial resistance in freshwater environments a public health risk?
2.30pm – 3pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Natural environments like rivers and lakes create ideal conditions for the emergence and spread of antimicrobial resistance (AMR), as they bring together environmental bacteria, pollutants, and antibiotic-resistant pathogens from human and animal origin. The introduction of anthropogenic waste—via untreated sewage, industrial discharge, and agricultural runoff—further supports the persistence and proliferation of AMR. Recreational activities in faecally-contaminated waters, such as freshwater swimming, may increase the risk of exposure to AMR bacteria and genes, though this link remains underexplored.
Speakers

Challenges posed by Cryptosporidium in the 21st century and the changing face of clinical cryptosporidiosis
Medical Microbiology
Challenges posed by Cryptosporidium in the 21st century and the changing face of clinical cryptosporidiosis
3pm – 3.30pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Cryptosporidium is a very common cause of gastroenteritis in the UK and one of the most important contributors to the burden of childhood diarrhoea morbidity and mortality globally. It is an organism of interest to those working in clinical, industrial, veterinary and agricultural settings and recent outbreaks have highlighted the lack of awareness of current guidance around Cryptosporidium.
Speakers
Professor Rachel Chalmers
Consultant Clinical Scientist, , Public Health Wales, Swansea
Using genomics for gastrointestinal illness – a public health revolution
Medical Microbiology
Using genomics for gastrointestinal illness – a public health revolution
4pm – 4.30pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
This presentation will discuss the shift from molecular techniques to whole genome sequencing (WGS) within a public health agency. Anaïs will explain the types of information that can be obtained through WGS and how this genomic data can be integrated with surveillance efforts to effectively respond to outbreaks. To illustrate this, Anaïs will provide examples of gastrointestinal outbreaks and how WGS has been used to enhance our response.
Speakers

Anaïs Painset
Lead Bioinformatician, Gastrointestinal Bacteria Reference Unit, UK Health Security Agency
Developing new diagnostics for Clostridium difficile infection
Medical Microbiology
Developing new diagnostics for Clostridium difficile infection
4.30pm – 5pm BST, 24 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Translational research has the power to change the lives of patients and to improve existing multi-step diagnostic pathways.
Bench to bedside research can be transformative when applied to critical healthcare associated pathogens.
Speakers

Infection post global bariatric healthcare
Medical Microbiology
Infection post global bariatric healthcare
9am – 9.20am BST, 25 September 2025 ‐ 20 mins
Medical Microbiology
Learning outcomes
Delegates will understand:
- The utility of multidisciplinary laboratory results to aid diagnosis
- The importance of communication between scientists and consultants
Always expect the unexpected: A case study
Medical Microbiology
Always expect the unexpected: A case study
9.20am – 9.40am BST, 25 September 2025 ‐ 20 mins
Medical Microbiology
Learning outcomes
Through the discussion of a case study delegates understand:
- Causes of acute arthritis
- Differential diagnosis and supplementary tests
- Looking at the whole picture: the role of microbiological tests and the clinical information
Speakers
Terbinafine-resistant Trichophyton indotineae: challenges in diagnosis and management
Medical Microbiology
Terbinafine-resistant Trichophyton indotineae: challenges in diagnosis and management
9.40am – 10am BST, 25 September 2025 ‐ 20 mins
Medical Microbiology
Learning outcomes
Delegates will be able to:
- To be able to identify T.indotiniae
- Be aware of the epidemiology of T.indotiniae
- Identify challenges in the treatment of T.indotiniae.
Speakers
An unusual case of necrotising fasciitis
Medical Microbiology
An unusual case of necrotising fasciitis
10.30am – 11am BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
- Importance of tissue samples/sterile fluids being sent to the laboratory
- Recognition and understanding of blood science results in relation to microbiology
- A better understanding of necrotising fasciitis and risk factors
Speakers
Thomas Smeeton
Higher Specialist Biomedical Scientist, Nottingham University Hospitals NHS Trust
Riding the epidemic wave: The challenges of Mycoplasma & Bordetella
Medical Microbiology
Riding the epidemic wave: The challenges of Mycoplasma & Bordetella
11am – 11.30am BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
This presentation will provide an overview of the current epidemiology for both Mycoplasma & Bordetella, methods for detection and considerations for infection prevention & control future.
Speakers

Dr Vicki Fleming
Consultant Clinical Scientist, Nottingham University Hospitals NHS Trust
Urine trouble: UTI diagnostics past & future
Medical Microbiology
Urine trouble: UTI diagnostics past & future
11.30am – 12pm BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
Delegates will:
- Gain perspective on how current UTI diagnostic tests came to become routine clinical microbiology laboratory practice
- Understand the problems with current POC and laboratory diagnostic tests for UTI
- Appreciate how new UTI diagnostic tests are being developed and how these might change the clinical landscape
- Think about the potential for a mixture of diagnostic approaches to UTI in the future
Speakers
Meet the Experts - The future is now: How do we move to metagenomics for Microbiology?
Medical Microbiology
Meet the Experts - The future is now: How do we move to metagenomics for Microbiology?
12.45pm – 2pm BST, 25 September 2025 ‐ 1 hour 15 mins
Medical Microbiology
UKAS accreditation of a metagenomics service
Medical Microbiology
UKAS accreditation of a metagenomics service
2pm – 2.30pm BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Making the future happen starts with the validation of services to ISO 15189 (2022).
Dr Brown explains the process of accreditation and the development of specialist metagenomic services to deliver translational medicine to patients in the NHS.
Speakers

Dr Julianne Brown
Principal Clinical Scientist, Great Ormond Street Hospital for Children NHS Foundation Trust
Partnership pipelines: Integrating next-generation sequencing into diagnostic services
Medical Microbiology
Partnership pipelines: Integrating next-generation sequencing into diagnostic services
2.30pm – 3pm BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Learning outcomes
Delegates will learn through an Illustrated example of how next generation sequencing using PromethION (Oxford Nanopore Technology) can be used to understand virulence and antimicrobial resistance gene expression.
Staph aureus blood stream infection carries a 30% mortality, developing a partnership sequencing pipeline within an infection research group can give real time analysis of virulence and transmission.
Speakers

Respiratory metagenomics implementation in the clinical laboratory, a unifed method for detection of bacteria, viruses and fungi
Medical Microbiology
Respiratory metagenomics implementation in the clinical laboratory, a unifed method for detection of bacteria, viruses and fungi
3pm – 3.30pm BST, 25 September 2025 ‐ 30 mins
Medical Microbiology
Abstract
Developing a routine respiratory metagenomic network that can scale up to support 20 NHS Trusts, demonstrating the future shape of NHS specialist services.
Presentation of a pipeline that includes groundbreaking methods of human DNA depletion for the direct sequencing of patient samples.
Speakers

Dr Adela Alcolea-Medina
Lead - Next Generation Sequencing, Synnovis - Guy’s and St Thomas’ Hospital
Opening and Closing Plenary programmes